Vaccines Market Analysis

Application {Viral Diseases (Influenza, Hepatitis, Herpes Zoster, Rubella, Rotavirus), Bacterial Diseases (Diphtheria, Meningococcal, Pneumococcal)}

The global vaccines market is segmented and analyzed for demand and supply by application into viral diseases (influenza, hepatitis, herpes zoster, rubella, rotavirus, and others), and bacterial diseases (diphtheria, meningococcal, pneumococcal, and others), out of which, the bacterial diseases segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the prevalence of bacterial diseases globally. For instance, in 2019, over 1 million people lost their lives due to antibiotic-bacterial resistant infections.

Our in-depth analysis of the global vaccines market includes the following segments:

By Type	Inactivated Recombinant Live Attenuated Toxoid
By Administration Route	Oral Parenteral
By Age Group	Adults Pediatric
By Application	Viral Diseases Influenza Hepatitis Herpes Zoster Rubella Rotavirus Others Bacterial Diseases Diphtheria Meningococcal Pneumococcal Others
By Distribution Channel	Government Supplier Hospitals Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of vaccines is assessed at USD 86.81 billion.

The vaccines market size was over USD 82.96 billion in 2024 and is anticipated to reach USD 171.11 billion by the end of 2037, growing at around 5.9% CAGR during the forecast period i.e., between 2025-2037. Growing demand for vaccines to cure hepatitis b and increasing cases of tuberculosis across the globe will boost the market growth.

Asia Pacific industry is likely to hold largest revenue share by 2037, owing to increment in birth rate, rising geriatric population and growing penetration of major key players in the region.

The major players in the market include Pfizer Inc., Sanofi Aventis, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Bavarian Nordic A/S, Novartis AG, Inovio Pharmaceuticals, Inc., CSL Limited, and others. .

Vaccines Market Analysis